- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04568746
Implementation of a qSOFA Score in the Emergency Department (qSOFA2)
January 15, 2025 updated by: Centre Hospitalier Universitaire de Besancon
Impact of the Implementation of a qSOFA Score on the Care of Adult Patients Referred to the Emergency Department for Suspected Infection
The Quick-SOFA score (qSOFA), identifies septic patients with a mortality risk higher than 10%.
In our study all adult patients coming to the emergency for suspected infection are screened according to the qSOFA score on arrival.
If qSOFA ≥ 2, the patient should be referred to emergency vital room, if the score <2, the patient will be in the box.
The objectives are : 1) to evaluate the mortality at 28 days with the orientation, 2) to compare support time of medical contact and initiation of antibiotics according to the orientation in the emergency department.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
104
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Besançon, France, 25000
- CHU Besançon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- body temperature below 36 °C or above 38 °C
- require hospitalization
Exclusion Criteria:
- hospital transfer,
- patients with pre hospital care
- language barrier,
- refusal to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: patients with qSOFA ≥ 2
adult patients with a qSOFA score ≥ 2 at the screening in the emergency department, will be referred to the emergency vital room
|
At the arrival of the patient, the qSOFA will be carried out to guide the orientation.
Patient with score ≥ 2 will be supported in emergency vital room
|
|
Other: patients with qSOFA <2
adult patients with a qSOFA score < 2 at the screening in the emergency department, will be referred to the box
|
patient with score < 2 will be supported in box
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mortality rate
Time Frame: 28 days
|
compare mortality rate with orientation in emergency
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
support time to medical contact
Time Frame: 1 day
|
compare support time with orientation of patients according to the orientation of the patient in the emergency department
|
1 day
|
|
support time to initiation of antibiotics
Time Frame: 1 day
|
compare support time with initiation antibiotics of patients according to the orientation of the patient in the emergency department
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 12, 2020
Primary Completion (Actual)
October 12, 2021
Study Completion (Actual)
November 12, 2021
Study Registration Dates
First Submitted
September 24, 2020
First Submitted That Met QC Criteria
September 24, 2020
First Posted (Actual)
September 29, 2020
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 15, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P/2019/452
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
Clinical Trials on emergency vital room
-
Sohag UniversityNot yet recruiting
-
Jewish General HospitalActive, not recruitingOlder People | Health Care | Health Impairment | EvaluationsCanada
-
Centre Hospitalier Universitaire de NīmesSociete Française de Medecine d'urgenceNot yet recruitingShock | Critical Illness | Respiratory Failure | Resuscitation | Trauma (Including Fractures) | Emergency Department Patient
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; South London and Maudsley NHS Foundation... and other collaboratorsUnknownClinical Skills TrainingUnited Kingdom
-
Hospital for Special Surgery, New YorkNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of OuluOulu University HospitalCompletedRespiratory Tract InfectionsFinland
-
Centre Hospitalier Universitaire de NīmesCompleted
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingAsthma in ChildrenUnited States
-
University of BristolCompleted
-
Centre Hospitalier Departemental VendeeRecruiting